Strategic Wealth Partners, Ltd. Sanofi Transaction History

Strategic Wealth Partners, Ltd.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	SELL	$45.75 - $52.48 $694,485 - $796,646	-15,180 Closed	0 $0
Q4 2023 May 20, 2024	SELL	$43.13 - $54.79 $1.92 Million - $2.43 Million	-44,415 Reduced 74.53%	15,180 $754,000
Q3 2023 May 20, 2024	SELL	$50.95 - $55.2 $357,872 - $387,724	-7,024 Reduced 10.54%	59,595 $3.2 Million
Q2 2023 May 20, 2024	SELL	$50.45 - $57.18 $26,839 - $30,419	-532 Reduced 0.79%	66,619 $3.59 Million
Q1 2023 Apr 24, 2023	SELL	$45.86 - $54.45 $48,978 - $58,152	-1,068 Reduced 1.57%	67,151 $3.65 Million
Q4 2022 Apr 24, 2023	SELL	$38.86 - $48.55 $85,181 - $106,421	-2,192 Reduced 3.11%	68,219 $3.3 Million
Q3 2022 Apr 24, 2023	BUY	$37.22 - $100.5 $2.62 Million - $7.08 Million	70,411 New	70,411 $2.68 Million
Q4 2019 Jan 30, 2020	SELL	$44.25 - $50.86 $13,452 - $15,461	-304 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$40.34 - $46.64 $9,358 - $10,820	-232 Reduced 43.28%	304 $13,000
Q2 2019 Aug 06, 2019	SELL	$40.43 - $44.3 $22,155 - $24,276	-548 Reduced 50.55%	536 $23,000
Q1 2019 May 14, 2019	SELL	$40.83 - $45.43 $3,674 - $4,088	-90 Reduced 7.67%	1,084 $48,000
Q4 2018 Jan 24, 2019	SELL	$41.48 - $45.59 $3,484 - $3,829	-84 Reduced 6.68%	1,174 $50,000
Q3 2018 Dec 06, 2018	SELL	$40.0 - $44.84 $14,840 - $16,635	-371 Reduced 22.77%	1,258 $56,000
Q2 2018 Sep 04, 2018	SELL	$37.63 - $41.22 $142,617 - $156,223	-3,790 Reduced 69.94%	1,629 $65,000
Q1 2018 Jul 13, 2018	BUY	$38.98 - $45.76 $211,232 - $247,973	5,419 New	5,419 $217,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $123B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.